Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Sarasota › NPI 1245294826
Clinic

Sarasota County Public Hospital District

Sarasota County Public Hospital District was paid $16.60M by Medicaid between Jan 2018 and Dec 2024, across 274 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.

33Billing provider infoSARASOTA COUNTY PUBLIC HOSPITAL DISTRICT
SARASOTA, FL 34239
33aNPI1245294826assigned 04/12/2006
33bProvider typeUrgent Care Clinic/Center
28Total paid$16.60M
24GClaims858,740
24DCodes billed274
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Urgent Care Clinic/Center providers in Florida

Rank by total paid#2 of 115
Median peer was paid$106K
This provider vs. median156×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201889,797$1.09M
2019162,031$2.49M
2020143,285$1.99M
2021200,683$3.59M
2022177,615$4.11M
202366,471$2.26M
2024incomplete18,858$1.07M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 22% 50,866 45,574 $3.67M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 21% 50,291 43,017 $3.46M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.4% 5,688 4,875 $723K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.5% 9,908 7,840 $589K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.9% 6,432 5,742 $480K
70450 Computed tomography, head or brain; without contrast material 2.8% 8,237 6,399 $457K
G0378 Hospital observation service, per hour 2.3% 8,170 5,302 $388K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.1% 7,075 1,787 $355K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.9% 2,897 2,455 $314K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.7% 6,372 3,329 $275K
84702 1.5% 12,407 10,534 $254K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.3% 18,716 15,075 $218K
262 more codes
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.3% 2,918 $210K
71275 Computed tomographic angiography, chest, with contrast material 1.3% 1,805 $209K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 11,390 $159K
80053 Comprehensive metabolic panel <1% 19,682 $152K
80048 Basic metabolic panel (calcium, ionized) <1% 45,120 $149K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 2,257 $140K
96361 Intravenous infusion, hydration; each additional hour <1% 3,200 $138K
72125 Computed tomography, cervical spine; without contrast material <1% 3,261 $135K
81001 <1% 30,352 $134K
84484 <1% 13,331 $125K
92650 <1% 3,037 $124K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,040 $124K
92587 <1% 3,922 $105K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 761 $105K
82948 <1% 11,881 $105K
86850 <1% 4,081 $94K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 230 $87K
71046 Radiologic examination, chest; 2 views <1% 5,110 $82K
80076 <1% 19,908 $79K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 5,581 $79K
71045 Radiologic examination, chest; single view <1% 18,615 $78K
81025 <1% 3,626 $78K
41899 Unlisted procedure, dentoalveolar structures <1% 216 $68K
76830 Ultrasound, transvaginal <1% 2,528 $67K
59025 Fetal non-stress test <1% 4,177 $64K
87086 Culture, bacterial; quantitative colony count, urine <1% 9,738 $63K
36415 Collection of venous blood by venipuncture <1% 20,737 $62K
76801 <1% 2,703 $59K
92586 <1% 1,147 $59K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,705 $57K
A9270 Non-covered item or service <1% 10,375 $55K
73610 <1% 1,728 $53K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 58,935 $53K
85610 <1% 12,827 $52K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,918 $51K
99214 Doctor's office visit, returning patient (more involved) <1% 505 $51K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,762 $50K
87430 <1% 1,546 $48K
73630 <1% 2,078 $48K
96375 Therapeutic injection; each additional sequential IV push <1% 11,125 $47K
97162 <1% 1,283 $46K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,427 $43K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 21,354 $41K
82565 <1% 4,044 $41K
C1769 Guide wire <1% 833 $40K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,345 $34K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,248 $34K
73130 <1% 1,259 $34K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,253 $33K
76818 <1% 399 $32K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,462 $32K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 79 $32K
76775 <1% 1,324 $30K
85027 <1% 9,366 $30K
J0690 Injection, cefazolin sodium, 500 mg <1% 2,850 $29K
84112 <1% 453 $28K
83735 <1% 22,222 $28K
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility <1% 94 $27K
87480 <1% 2,943 $26K
83880 <1% 3,693 $25K
86901 <1% 5,666 $25K
12011 <1% 455 $25K
87070 <1% 2,184 $25K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,815 $25K
73564 <1% 1,422 $23K
70486 <1% 540 $23K
73110 <1% 1,199 $23K
99213 Doctor's office visit, returning patient (routine) <1% 415 $23K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 404 $22K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 10,696 $22K
73030 <1% 1,461 $21K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 313 $21K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 2,107 $21K
12001 <1% 453 $20K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,724 $20K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,970 $20K
74018 <1% 718 $19K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,328 $19K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,063 $19K
93971 <1% 924 $17K
84443 Thyroid stimulating hormone (TSH) <1% 6,915 $16K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 318 $15K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,041 $14K
85730 <1% 5,110 $14K
87280 <1% 442 $13K
71250 <1% 623 $13K
J7030 Infusion, normal saline solution , 1000 cc <1% 14,273 $13K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 218 $13K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,754 $12K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 231 $12K
96376 <1% 4,372 $12K
36430 <1% 295 $12K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 4,002 $12K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,550 $11K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 344 $11K
73080 <1% 273 $11K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 650 $11K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 432 $11K
P9016 Red blood cells, leukocytes reduced, each unit <1% 391 $11K
82247 <1% 1,493 $10K
76641 <1% 240 $10K
84439 <1% 2,097 $10K
73090 <1% 435 $10K
73590 <1% 584 $9K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 54 $9K
72100 <1% 523 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,886 $9K
83605 <1% 1,944 $9K
99215 Doctor's office visit, returning patient (complex) <1% 99 $8K
72131 <1% 222 $8K
87081 <1% 2,441 $8K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 109 $8K
86900 <1% 5,288 $8K
87186 <1% 2,168 $7K
87205 <1% 2,405 $7K
J7120 Ringers lactate infusion, up to 1000 cc <1% 5,386 $7K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,175 $7K
84703 <1% 199 $6K
87420 <1% 583 $6K
74022 <1% 329 $6K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,435 $6K
12002 <1% 151 $6K
73502 <1% 629 $6K
76642 <1% 127 $6K
70100 <1% 156 $6K
83690 <1% 15,982 $6K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,906 $5K
29581 <1% 278 $5K
87075 <1% 1,164 $5K
70551 Magnetic resonance imaging, brain; without contrast material <1% 130 $5K
80069 <1% 3,474 $5K
82550 <1% 1,035 $5K
87110 <1% 339 $5K
49083 <1% 17 $5K
87077 <1% 1,613 $4K
82077 <1% 732 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 227 $4K
97161 <1% 115 $4K
80051 <1% 662 $4K
85379 <1% 2,237 $4K
76536 <1% 62 $4K
85014 <1% 1,326 $3K
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 283 $3K
77066 Tomosynthesis, mammo <1% 87 $3K
73140 <1% 74 $3K
10060 <1% 97 $3K
80061 Lipid panel <1% 5,280 $3K
73560 <1% 185 $3K
86140 <1% 2,813 $3K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 115 $3K
87040 <1% 2,706 $3K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 82 $3K
82803 <1% 515 $3K
87088 <1% 3,356 $3K
76819 Fetal biophysical profile; without non-stress testing <1% 83 $3K
84156 <1% 2,432 $3K
88304 <1% 108 $3K
70491 <1% 28 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 23 $2K
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 79 $2K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 66 $2K
87660 <1% 2,868 $2K
70496 <1% 15 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 4,849 $2K
82947 <1% 740 $2K
80143 <1% 95 $2K
87510 <1% 2,853 $2K
70498 <1% 14 $2K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 42 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,801 $1K
90715 <1% 989 $1K
82728 <1% 1,168 $1K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 195 $1K
82607 <1% 2,137 $1K
72170 <1% 580 $1K
77080 <1% 78 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 691 $1K
85651 <1% 2,188 $1K
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) <1% 28 $1K
73552 <1% 67 $1K
95819 <1% 15 $1K
G0379 Direct admission of patient for hospital observation care <1% 63 $1K
82150 <1% 805 $1K
72040 <1% 78 $1K
82570 <1% 3,116 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 16 $1K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 315 $991.95
83970 <1% 184 $933.97
86923 <1% 147 $922.54
J1650 Injection, enoxaparin sodium, 10 mg <1% 2,765 $774.34
83540 <1% 1,367 $764.10
82746 <1% 1,261 $754.76
87340 <1% 1,002 $743.53
84481 <1% 49 $730.80
84520 <1% 727 $698.79
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 41 $610.68
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,966 $596.85
76870 <1% 14 $595.86
80329 <1% 64 $595.24
83550 <1% 1,087 $582.67
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 38 $567.34
82731 <1% 15 $513.19
77063 Screening digital breast tomosynthesis, bilateral <1% 565 $440.40
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 62 $386.27
84550 <1% 231 $358.15
99217 <1% 14 $328.26
73060 <1% 35 $327.90
82248 <1% 1,725 $326.28
85007 <1% 2,345 $313.45
87449 <1% 51 $309.17
80074 <1% 13 $292.48
84132 <1% 386 $289.79
73070 <1% 31 $266.39
J2550 Injection, promethazine hcl, up to 50 mg <1% 359 $264.42
86780 <1% 100 $248.80
A9578 Injection, gadobenate dimeglumine (multihance multipack), per ml <1% 296 $192.67
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,072 $182.36
90686 <1% 50 $153.89
73100 <1% 31 $112.92
84155 <1% 459 $109.76
L8699 Prosthetic implant, not otherwise specified <1% 26 $87.14
86308 <1% 74 $86.05
82043 <1% 441 $76.69
87641 <1% 21 $62.64
80164 <1% 19 $62.46
87015 <1% 33 $48.86
84100 <1% 623 $48.63
00170 Anesthesia for intraoral procedures, including biopsy <1% 46 $39.47
77065 Tomosynthesis, mammo <1% 13 $31.37
84460 <1% 402 $28.00
82010 <1% 187 $24.64
88342 <1% 96 $23.96
86803 <1% 16 $21.72
97116 <1% 28 $21.14
84145 <1% 47 $17.91
A9576 Injection, gadoteridol, (prohance multipack), per ml <1% 16 $15.04
86920 <1% 20 $12.51
82140 <1% 37 $11.65
85018 <1% 136 $9.81
84450 <1% 348 $7.39
85046 <1% 38 $3.66
84075 <1% 235 $1.48
80305 <1% 13 $0.52
J2704 Injection, propofol, 10 mg 0% 15 $0.00
87116 0% 33 $0.00
87206 0% 39 $0.00
J1885 Injection, ketorolac tromethamine, per 15 mg 0% 13 $0.00
87581 0% 82 $0.00
87486 0% 82 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 39 $0.00
82657 0% 13 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 30 $0.00
71101 0% 14 $0.00
88307 0% 13 $0.00
83615 0% 15 $0.00
J0692 Injection, cefepime hydrochloride, 500 mg 0% 27 $0.00
87400 0% 16 $0.00
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 0% 98 $0.00
96367 0% 81 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 18 $0.00
87101 0% 17 $0.00
29125 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVERINDER, DAVID (PRESIDENT & CHIEF EXECUTIVE OFFICER)
Same official

Other billing entities under VERINDER, DAVID

Full network →
ProviderLocationPaid
Sarasota County Public Hospital DistrictNorth Venice, FL$836K
Sarasota County Public Hospital DistrictSarasota, FL$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.